Antithyroid drugs in Graves’ disease: Are we stretching it too far?

INTRODUCTION: Early and durable achievement of euthyroid or hypothyroid status with low likelihood of relapse is the key to effective treatment of Graves’ disease (GD). Although antithyroid drugs (ATDs) are commonly used first-line agents, likelihood of remission remains highest with radioactive iod...

Descripción completa

Detalles Bibliográficos
Autores principales: Jayaraman, Muthukrishnan, Pawah, Anil Kumar, Narayanan, C. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040037/
https://www.ncbi.nlm.nih.gov/pubmed/27730067
http://dx.doi.org/10.4103/2230-8210.190525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040037/
https://www.ncbi.nlm.nih.gov/pubmed/27730067
http://dx.doi.org/10.4103/2230-8210.190525

Ejemplares similares